|
Issue |
Title |
|
Vol 2021, No 4 (2021) |
HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure |
Abstract
PDF
|
William Grigg, Faisal Mahfooz, Dharmista Chaudhary, Isain Zapata, Douglas Duffee |
|
Vol 2012, No 1 (2012) |
Heart failure with preserved ejection fraction |
Abstract
PDF
|
Ahmed ElGuindy, Magdi H Yacoub |
|
Vol 2018, No 2 (2018) |
Heart transplantation at 50+: Celebrations and challenges |
Abstract
PDF
|
Magdi Yacoub, Asghar Khaghani |
|
Vol 2018, No 3 (2018) |
Heart transplantation in patients with hypertrophic cardiomyopathy |
Abstract
PDF
|
Marta Farrero Torres, Felix Perez-Villa |
|
Vol 2014, No 1 (2014) |
HEAT-PPCI: A clear and welcome win for heparin |
Abstract
PDF
|
Ahmed M ElGuindy |
|
Vol 2018, No 2 (2018) |
Heparin-induced thrombocytopenia (HIT): Identification and treatment pathways |
Abstract
PDF
|
Mahmoud Fathi |
|
Vol 2021, No 2 (2021) |
High output heart failure as a result of an ilio-caval fistula with a negative shunt series |
Abstract
PDF
|
Travis R Huffman, Nadine Sbaih, Mohammad Mathbout, Shahab Ghafghazi |
|
Vol 2015, No 2 (2015) |
High prevalence of raised lipoprotein(a) in patients with refractory angina |
Abstract
PDF
|
Tina Z Khan, Samantha Rhodes, Alsion Pottle, Winston Banya, Robert Smith, Tito Kabir, Charles Ilsley, Dudley J Pennell, Mahmoud Barbir |
|
Vol 2018, No 3 (2018) |
Histopathology in HCM |
Abstract
PDF
|
Beatriz San Millán Tejado, Cristina Jou |
|
Vol 2013, No 4 (2013) |
Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism |
Abstract
PDF
|
Karim Said |
|
Vol 2016, No 2 (2016) |
Hope for primary cardiovascular prevention with the HOPE (Heart Outcomes Prevention Evaluation)-3 trial findings |
Abstract
PDF
|
Jassim Al Suwaidi |
|
Vol 2017, No 3 (2017) |
How a simple medical observation led to increased awareness and propagation of research in Kawasaki disease in Egypt |
Abstract
PDF
|
Galal El Said, Sherif Rizk, Khaled Sorour, Soliman Gharib, Karim Said, Hossam Kandeel |
|
Vol 2018, No 1 (2018) |
How are countries dealing with their current cardio-vascular disease burden? A snapshot from the WHO Eastern Mediterranean Region (EMR) |
Abstract
PDF
|
Asmus Hammerich |
|
Vol 2014, No 3 (2014) |
HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack |
Abstract
PDF
|
Mohamed Hassan |
|
Vol 2017, No 1 (2017) |
Hydatid cyst of the interventricular septum |
Abstract
PDF
|
Endale Tefera, Joseph Knapp, Michael Teodori |
|
Vol 2013, No 3 (2013) |
Hydrogel scaffolds for tissue engineering: Progress and challenges |
Abstract
PDF
|
Ibrahim M El-Sherbiny, Magdi H Yacoub |
|
Vol 2021, No 3 (2021) |
Hypertriglyceridaemia: Contemporary management of a neglected cardiovascular risk factor |
Abstract
PDF
|
Tina Z Khan, Ulrike Schatz, Stefan R Bornstein, Mahmoud Barbir |
|
Vol 2018, No 1 (2018) |
Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus |
Abstract
PDF
|
Munis Raza, Nagib Chalfoun, Abdallah Wissam, Hamza Hashmi, Richard McNamara |
|
Vol 2018, No 3 (2018) |
Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia |
Abstract
PDF
|
Tomas Ripoll-Vera, Jorge Alvarez-Rubio |
|
Vol 2018, No 3 (2018) |
Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults |
Abstract
PDF
|
Paloma Jordà, Ana García-Álvarez |
|
Vol 2012, No 1 (2012) |
Hypertrophic cardiomyopathy: The first century 1869–1969 |
Abstract
PDF
|
Eugene Braunwald |
|
Vol 2013, No 3 (2013) |
Hypertrophic cardiomyopathy: The need for randomized trials |
Abstract
PDF
|
Iacopo Olivotto, Benedetta Tomberli, Roberto Spoladore, Alessandro Mugelli, Franco Cecchi, Paolo G Camici |
|
Vol 2011, No 1 (2011) |
Impact of 3D echocardiography on mitral valve surgery |
Abstract
PDF
|
Pravin M Shah, Aidan A Raney |
|
Vol 2021, No 2 (2021) |
Impact of human immunodeficiency virus on pulmonary vascular disease |
Abstract
PDF
|
Ashok Kumar, Aatish Mahajan, Ethan A Salazar, Kevin Pruitt, Christian Arce Guzman, Matthias A Clauss, Sharilyn Almodovar, Navneet K Dhillon |
|
Vol 2018, No 3 (2018) |
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy |
Abstract
PDF
|
Diego Jimenez Sanchez, Ignacio Fernández Lozano |
|
151 - 175 of 402 Items |
<< < 2 3 4 5 6 7 8 9 10 11 > >> |